GLP-1 Journey Planner
Step-by-step GLP-1 journey
GLP-1 Weight Loss Timeline: What to Expect
| Phase | Weeks | Dose Range | Expected Progress | Notes |
|---|---|---|---|---|
| Initiation | 1-4 | Starting dose | 2-4% weight loss | GI adaptation period |
| Escalation | 5-16 | Increasing | 5-10% weight loss | Most side effects here |
| Optimization | 17-24 | Near-max | 10-15% weight loss | Finding maintenance dose |
| Maintenance | 25+ | Stable | 15-20%+ total | Long-term plateau management |
Anchored to STEP-1 (semaglutide 2.4 mg, 68 weeks) and SURMOUNT-1 (tirzepatide 5–15 mg, 72 weeks) endpoints. Your curve depends on the dose you reach, whether you hit protein, and whether training is in place.
Breaking Through GLP-1 Plateaus
Why Plateaus Happen
Your body adapts to weight loss by lowering resting energy burn — Coutinho 2020 quantified the adaptive thermogenesis component at ~150 kcal/day, persisting beyond 52 weeks. This isn't receptor tolerance; it's a deficit closing as weight drops. The plateau is physiology, not failure. See Stopping GLP-1s for the full mechanism breakdown.
When to Titrate Up
Dose increase earns its place when appetite is returning, weight has been stable 3+ weeks, and GI side effects are manageable at the current dose. Not before. STEP and SURMOUNT escalation protocols wait 4 weeks between steps for a reason — the body needs time to resolve the previous step before you stack the next one.
Protein and Training
Muscle preservation is the single biggest lever against plateau and regain. Target ≥1.6 g/kg protein daily, distributed across 3–4 meals. Pair with 3 resistance sessions per week — every pound of lean mass retained is 6–10 kcal/day of baseline energy burn that does not disappear.
Switching Compounds
The three compounds are different receptor strategies, not different doses of the same drug. Switching from semaglutide to tirzepatide adds GIP signaling and better lean-mass sparing; retatrutide adds a glucagon-driven thermogenic arm the other two don't have. See compound comparison before picking the next one.
Frequently Asked Questions
How long does it take to lose weight on semaglutide?
Measurable loss shows up in the first 4 weeks. STEP-1 milestones for the 2.4 mg arm ran roughly 5% by week 12, 10% by week 24, and ~15% by week 68 — SURMOUNT-1 tracked similar timing for tirzepatide with a steeper curve at 72 weeks. Individual results vary with starting weight, dose tolerance, and whether protein and resistance training lock in during the escalation phase.
What should I do if I hit a plateau on GLP-1?
Plateaus at weeks 12–16 and again around week 28–36 are the adaptive response to weight loss, not the drug failing. The plateau usually resolves with structural fixes before dose escalation: protein at ≥1.6 g/kg distributed across meals, 3 resistance sessions per week, and checking whether sleep and alcohol have quietly drifted. If weight stays stable for 4+ weeks at a fully titrated dose with those pieces in place, a dose increase or compound switch is the next move.
How long until I reach my goal weight on semaglutide?
STEP-1 ran 68 weeks and the average loss at endpoint was ~15% of body weight. If you need to lose 15%, plan for roughly 12–18 months on-drug. For 20%+ loss, 18–24 months is more realistic, and tirzepatide (SURMOUNT-1 ran 72 weeks, ~21% average loss) is typically the better choice for that target. Weight loss is not linear — expect faster progress in months 2–6 and slower progress near the endpoint.
When do semaglutide side effects stop?
GI side effects cluster around each STEP escalation step — nausea, reduced appetite, and constipation typically peak 2–3 days after a dose increase and fade over 2–4 weeks at a stable dose. Most people report minimal ongoing symptoms by month 3–4 once at their maintenance dose. If a step-up is intolerable, holding the current dose for an extra 2–4 weeks or splitting the dose across the week usually solves it.
How do I know if my GLP-1 dose is working?
An effective dose reduces hunger between meals, produces earlier satiety, lowers food noise, and drives gradual weight loss of roughly 0.5–2 lb per week. If appetite has returned to baseline and weight has been stalled for 3+ weeks with protein and training in place, the dose is no longer doing its mechanical job and a step up is reasonable.
Can I stop taking GLP-1 after reaching goal weight?
Without a protocol, roughly two-thirds of the weight lost on semaglutide returns within 52 weeks — that number comes from the Wilding 2022 STEP-1 extension. Aronne 2024 SURMOUNT-4 measured ~14% body weight regain on tirzepatide placebo-switch over the same window. Tapering, ≥1.6 g/kg protein, and resistance training starting during the taper (not after) is what separates the people who hold from the people who regain. See Stopping GLP-1s for the full taper protocol.
Related Resources
Medical Disclaimer
The content in this GLP-1 journey planner is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before beginning any new protocol, supplement, or medication.